Choose another country or region to see content specific to your location.
Disclaimer

This website is not intended for use in the province of Quebec.

Medical Education

Advance your knowledge, skills and expertise with continuous training and education programs.

Advance your knowledge, skills and expertise with continuous training and education programs

Continuing Medical Education

Join Medscape's expert faculty for a CME activity on the consequences of drug-resistant epilepsy and the use of neuromodulation in the management of patients with DRE.

Drug-Resistant Epilepsy: Hot Topics in the Use of Neuromodulation
Authors: Patrick Kwan, MD, BChir, FRACP, PhD; Jukka Peltola, MD PhD; Rainer Surges, MD, PhD; Stephen Karceski, MD; Robert Fisher, MD, PhD; John Stern, MD; Christianne Heck, MD, MMM, FAES

Drug-Resistant Epilepsy: Hot Topics in the Use of Neuromodulation

The goal of this activity is to improve clinicians’ understanding of drug-resistant epilepsy (DRE) and clinical trial findings regarding neuromodulation devices to help clinicians make evidence-based decisions about the use of neuromodulation devices in patients with DRE.

Upon completion of this activity, participants will have increased knowledge regarding:

  • Consequences of drug-resistant epilepsy for patients
  • Factors to consider when selecting an appropriate neuromodulation therapy for patients with drug-resistant epilepsy 
  • Long-term clinical data on the use of neuromodulation in patients with drug-resistant epilepsy

Email Alerts

Subscribe to our healthcare professionals email alert service to receive the latest VNS Therapy related news on a variety of subjects including: upcoming webinars and events, highlights from past events, publication announcements and more.

Register

This website is intended for healthcare professionals in Canada. VNS Therapy™ for drug-resistant epilepsy is not available in all regions - please refer to your country-specific labeling.